| Name | Title | Contact Details |
|---|
Electrify America, LLC is a prominent electric vehicle (EV) charging network in the United States, established in 2016 as a subsidiary of Volkswagen Group of America. The company aims to promote Zero-Emission Vehicle (ZEV) adoption by creating a nationwide network of ultra-fast and convenient EV charging stations. As of August 2024, Electrify America operates over 950 charging stations with more than 4,250 DC fast charging connectors, making it the largest open DC fast-charging network in the country. The company focuses on providing reliable and accessible hyper-fast charging solutions, supporting multiple connector types, including CCS and CHAdeMO, with plans to add Tesla’s North American Charging Standard (NACS) connectors in 2025. Electrify America is committed to sustainability, ensuring that all energy supplied to drivers is backed by 100% renewable energy certificates, and aims for a net zero carbon footprint. Headquartered in Reston, Virginia, the company employs around 300 people and actively engages in community education to promote equitable electrification.
Kinney Recruiting is home of some of the most respected legal recruiters in the world, proudly serving markets around the globe. Kinneys Asia practice includes Hong Kong, Tokyo, Beijing, Shanghai, and Singapore, among others. Our U.S. services focus on Arizona, California, Florida, Texas, and New York. Additionally, Kinney Recruiting is active in Dubai, London, Moscow, and the rest of Europe. If you are interested in legal recruiting services for your organization, or if you are a potential candidate for our services, please browse our site until you are comfortable with our philosophy and practices. Kinney Recruiting is committed to serving our clients interests in an ethical and effective manner, ultimately matching the right candidate with the perfect job. Contact us today to start your search!
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Purposeful Design is a Christian ministry that exists to help rebuild lives of individuals who have struggled with addiction, homelessness, incarceration and other obstacles; to equip them with valuable work skills; and to provide the gift of work (Genesis 2:15, Matthew 28:16-20, Ephesians 2:8-10).